Skip to main content

Solarcaine First Aid Medicated Spray Disease Interactions

There is 1 disease interaction with Solarcaine First Aid Medicated Spray (benzocaine topical).

Moderate

Benzocaine (applies to Solarcaine First Aid Medicated Spray) methemoglobinemia

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: G-6-PD Deficiency

Rarely, benzocaine has induced methemoglobinemia resulting in respiratory distress and cyanosis. Therapy with benzocaine should be administered cautiously to patients with or predisposed to methemoglobinemia. If life-threatening or severe methemoglobinemia develops, methylene blue infused at a dosage of 1 to 2 mg/kg body weight will rapidly reverse or improve the condition except in G-6-PD-deficient patients.

References

  1. (2001) "Product Information. Americaine (benzocaine topical)." Novartis Consumer Health
  2. (2001) "Product Information. Americaine Otic (benzocaine otic)." Medeva Pharmaceuticals

Solarcaine First Aid Medicated Spray drug interactions

There are 46 drug interactions with Solarcaine First Aid Medicated Spray (benzocaine topical).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.